Governor Jim Doyle's ambitious proposal to support Wisconsin's biotechnology industry guarantees that the practice of stem cell research will be part of the debate over the 2005-07 state budget. The debate presents Wisconsin's citizens with an opportunity to ponder a number of ethical and moral questions. Ethical questionsStem cell research is complex science involving "cutting edge" thinking and discovery. To the extent that stem cells are taken from people who have already been born, the ethical questions are less grave. However, to the extent that stem cells are procured by destroying human embryos this debate will include the fundamental moral question of how much our society values vulnerable human life. Ethics versus profitFrom this fundamental moral question, other questions with moral implications will flow. This is significant in light of recent political debates. We heard in the recent election campaign that moral values are more important than economic benefits. The moral issues implicated in the coming debate will give citizens and legislators a number of opportunities to test that argument. The U.S. bishops taught in their pastoral letter on the US economy, Economic Justice for All, that the economy exists to serve people, not the other way around. As this debate proceeds, Catholics must ask whether the profit motive will trump ethical and moral considerations regarding the value of human life. In a number of ways, the discussion over biotechnology will compel us to ask, "What is the importance of ethics versus profit?" Embryonic stem cellsOne such question will be: Why emphasize embryonic stem cells over research on stem cells taken from adults? Research on adult stem cells does not require the destruction of embryos. There is evidence that such research can also offer hope for current and future medical and scientific breakthroughs. Why is this road not emphasized? Is it because the potential benefit is limited? Or, is it because Wisconsin's early experience is with embryonic stem cell research and "shifting gears" will be more expensive? Commercial benefitsAnother inquiry flows from that part of the new initiative that facilitates the process by which university researchers may become commercial entrepreneurs to financially benefit from their discoveries. This blurring of the line between the academy and market place raises yet another set of ethical concerns. Hence the question, "Will the citizens who fund taxpayer subsidized research share in the health benefits derived from their investment, particularly when so many lack access to affordable health care?" Indeed, the eagerness of policy makers to encourage biotechnology is deeply grounded in terms of economic development. Thus we need to consider: Is the science in this instance motivated by a purely academic desire for knowledge that serves the common good, or is it motivated by money? How does this financial interest skew the focus of research and resources and blind us to the ethical issues at stake? What does history tell us about the "trickling down" of the health benefits of scientific discoveries? These are only some of the important questions that must be part of the coming debate over the biotechnology initiative. They do not lend themselves to 30-second sound bites or catchy slogans. But our capacity to debate these issues will say much about our capacity to exercise informed and faithful citizenship. John Huebscher is executive director of the Wisconsin Catholic Conference.
Diocese of Madison, The Catholic Herald Offices: Bishop O'Connor Catholic Pastoral Center, 702 S. High Point Road, Madison Mailing address: P.O. Box 44985, Madison, WI 53744-4985 Phone: 608-821-3070 Fax: 608-821-3071 E-Mail: info@madisoncatholicherald.org |